CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$56.00 +1.91 (+3.53%)
At close: Sep 29, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) FCF Margin (2016 - 2026)

Updated

CRISPR Therapeutics AG (CRSP) recorded FCF Margin of -826.50% in Q2 2026, up 11953.43 percentage points from -12779.93% a year earlier and up 6677.00 percentage points from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) FCF Margin (2016 - 2026) Analysis & Trends

On a TTM basis, CRISPR Therapeutics AG's FCF Margin came in at -2772.74% as of Jun 30, 2026, down 1917.11 percentage points year-over-year; for FY2025, it was -9855.50%, down 9467.78 percentage points from FY2024.

  • Annual FCF Margin has a five-year change of +25850.20 percentage points (FY2020 to FY2025).
  • Across earlier years, FCF Margin came in at -387.72% in FY2024 (-315.03 pp), -72.69% in FY2023 (+44412.20 pp), -44484.89% in FY2022 (-44534.87 pp) and 49.98% in FY2021 (+35755.68 pp).
  • The Q2 2026 figure is the highest quarterly FCF Margin since Q4 2024.
  • On a year-over-year basis, FCF Margin rose in three of the last seven quarters, with an average year-over-year change of -1970.70 percentage points.
  • Peak year-over-year performance for FCF Margin in the last five years was a gain of 1991935.22 percentage points in Q4 2023, against a drop of 1991245.13 percentage points in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -7503.50% (Q1 2026), -10771.99% (Q4 2025) and -9528.46% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 CRISPR Therapeutics AG 5.23 Bn 5.23 Bn - -826.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -826.50%
Mar 31, 2026 -7,503.50%
Dec 31, 2025 -10,771.99%
Sep 30, 2025 -9,528.46%
Jun 30, 2025 -12,779.93%
Mar 31, 2025 -6,260.46%
Dec 31, 2024 -140.89%
Sep 30, 2024 -17,796.01%
Jun 30, 2024 -18,624.56%
Mar 31, 2024 21,633.13%
Dec 31, 2023 -48.12%
Jun 30, 2023 -195.43%
Mar 31, 2023 5.74%
Dec 31, 2022 -1,991,983.33%
Sep 30, 2022 -118,335.11%
Jun 30, 2022 -95,940.51%
Mar 31, 2022 -16,020.11%
Dec 31, 2021 -738.20%
Sep 30, 2021 -14,366.26%
Jun 30, 2021 86.44%
API Access

CRISPR Therapeutics AG FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEY